FAILURE OF HEPARIN THERAPY TO AFFECT THE CLINICAL COURSE OF SEVERE PRE‐ECLAMPSIA

In view of the association between pre‐eclampsia and disseminated intravascular coagulation, three patients presenting with severe pre‐eclampsia before the 28th week of pregnancy were treated with heparin. In all three patients, there was deterioration of hypertension and proteinuria that necessitated the withdrawal of treatment after five to six days. During treatment, serum and urinary fibrinolytic degradation products (FDPs) continued to rise or remained unaltered, plasminogen levels showed a steady fall, and the platelet count remained at a reduced level. These data suggest that heparin was an ineffective form of treatment and did not prevent the intravascular fibrin deposition associated with severe pre‐eclampsia.

[1]  W. Muir,et al.  A Method for the Measurement of Platelet Adhesiveness by Use of Dialysis Membranes in a Test‐Cell , 1973, British journal of haematology.

[2]  R. Lindsay,et al.  Haemostatic Changes during Dialysis Associated with Thrombus Formation on Dialysis Membranes , 1972, British medical journal.

[3]  F. Preston,et al.  Intravascular coagulation and pre-eclamptic toxaemia. , 1972, Lancet.

[4]  C. Prentice,et al.  COAGULATION, FIBRINOLYSIS AND PLATELET FUNCTION IN PRE‐ECLAMPSIA, ESSENTIAL HYPERTENSION AND PLACENTAL INSUFFICIENCY , 1971, The Journal of obstetrics and gynaecology of the British Commonwealth.

[5]  H. J. Goldsmith,et al.  Delivery of healthy infant after five weeks' dialysis treatment for fulminating toxaemia of pregnancy. , 1971, Lancet.

[6]  A. S. Douglas,et al.  Coagulation and Fibrinolytic Systems in Pre-eclampsia and Eclampsia , 1971, British medical journal.

[7]  D. Pugsley,et al.  Fibrin Degradation Products in Pre-eclamptic Toxaemia and Eclampsia , 1970 .

[8]  V. Gurewich,et al.  Streptokinase in acute pulmonary embolism. , 1970, The Journal of thoracic and cardiovascular surgery.

[9]  J. Hirsh,et al.  Clinical Experience with Anticoagulant Therapy During Pregnancy , 1970 .

[10]  J I Robertson,et al.  Microangiopathic haemolytic anaemia and the pathogenesis of malignant hypertension. , 1969, Lancet.

[11]  E. N. Wardle,et al.  Fibrinolysis in Pre-eclamptic Toxaemia of Pregnancy , 1969, British medical journal.

[12]  P. Kincaid‐smith,et al.  Anticoagulants in "irreversible" acute renal failure. , 1968, Lancet.

[13]  A. S. Douglas,et al.  The Effect on Dipyridamole on Platelet Aggregation and Adhesiveness , 1968, Scottish medical journal.

[14]  R. Gorlin,et al.  Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. , 1968, The New England journal of medicine.

[15]  H. Kaunitz,et al.  Experimental ecalampsia. An eelctron microscope study and review. , 1967, Archives of pathology.

[16]  C. Merskey,et al.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. , 1966, Blood.

[17]  A. J. Honour,et al.  Effect of a Pyrimidopyrimidine Derivative on Thrombus Formation in the Rabbit , 1965, Nature.

[18]  Flávio Maciel de Freitas,et al.  General Circulatory Alterations Induced by Intravenous Infusion of Synthetic Bradykinin in Man , 1964 .

[19]  P. Vassalli,et al.  THE PATHOGENIC ROLE OF FIBRIN DEPOSITION IN THE GLOMERULAR LESIONS OF TOXEMIA OF PREGNANCY , 1963, The Journal of experimental medicine.

[20]  W. B. Robertson,et al.  A STUDY OF THE VESSELS OF THE PLACENTAL BED IN NORMOTENSIVE AND HYPERTENSIVE WOMEN , 1958, The Journal of obstetrics and gynaecology of the British Empire.

[21]  A. Govan.  Renal changes in eclampsia. , 1954, The Journal of pathology and bacteriology.

[22]  A. Hertig,et al.  The pathologic anatomy of eclampsia, bilateral renal cortical necrosis, pituitary necrosis, and other acute fatal complications of pregnancy, and its possible relationship to the generalized Shwartzman phenomenon. , 1953, American journal of obstetrics and gynecology.

[23]  O. Ratnoff,et al.  A new method for the determination of fibrinogen in small samples of plasma. , 1951, The Journal of laboratory and clinical medicine.

[24]  H. Taylor,et al.  The relationship of disorders of the blood-clotting mechanism to toxemia of pregnancy and the value of heparin in therapy. , 1950, American journal of obstetrics and gynecology.

[25]  P. Cohen,et al.  Partial purification and properties of a proteolytic enzyme of human serum. , 1949, The Journal of biological chemistry.

[26]  E. W. Page.  Use of heparin in pre-eclampsia , 1948 .

[27]  J. Maeck,et al.  Heparin in the treatment of toxemia of pregnancy; a preliminary report. , 1948, American journal of obstetrics and gynecology.